慢性病贫血的诊断及治疗进展

[1]	WEISS G,GOODNOUGH L T.Anemia of chronic disease[J].N Engl J Med,2005,352:1011-1023.
[2]	THEURL I,AIGNER E,THEURL M,et al.Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications[J].Blood,2009,113:5277-5286.
[3]	林凤茹.慢性病贫血和肾性贫血[J].中国实用内科杂志,2009,29(7):607-610.
[4]	李蓉生.应重视慢性病贫血的诊断和治疗[J].中华血液学杂志,1999,20(11):565-566.
[5]	AAPRO M,OSTERBORG A,GASCóN P,et al.Prevalence and management of cancer-related anaemia,iron deficiency and the specific role of i.v.iron[J].Ann Oncol,2012,23:1954-1962.
[6]	STEINMETZ H T.The role of intravenous iron in the treatment of anemia in cancer patients[J].Therapeutic Adv Hematol,2012,27.[Epub ahead of print].
[7]	KARLSSON T.Effects of iron supplementation on erythropoietic response in patients with cancer-associ ated anemia treated by means of erythropoietic stimulating agents[J].ISRN Hematol,2011,2011:108397-108403.
[8]	THOMAS C,THOMASA L.Biochemical Markers and Hematologic Indices in the Diagnosis of Functional Iron Deficiency[J].Clin Chem,2002,48:1066-1076.
[9]	TSUBAKIHARA Y,NISHI S,AKIBA T,et al.2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease[J].Ther Apher Dial,2010,14:240-275.
[10]	RIZZO J D,BROUWERS M,HURLEY P,et al.American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer[J].Blood,2010,116:4045-4059.
[11]	SCHRIJVERS D.Management of anemia in cancer patients: transfusions[J].Oncologist,2011,16 Suppl 3:12-18.
[12]	AUERBACH M,BALLARD H.Clinical use of intravenous iron: administration,efficacy,and safety[J].Hematol Am Soc Hematol Educ Program,2010,2010:338-347.